Home | Newest Editions | Most Popular Issues | Free Newsletters | Forums

Custom Search
Publication: Health Tips Weekly
Heart Attack Blood Vessel Damage Repaired

Subscribe FREE to Health Tips Weekly by clicking here.



       HEALTH TIPS WEEKLY - Thursday, September 13, 2007 
             "News That Keeps You Healthy"   
------------------------------------------------------------

You can discuss this issue or any other topic in the new 
Health Tips forum. Check it out here...


Health Tips Forum
------------------------------------------------------------

       Better, cost-effective respirators studied

CAMBRIDGE, Mass., -- U.S. scientists said the human body's 
ability to adapt to recurring stimuli might be used to 
design more effective, inexpensive artificial respirators.
Massachusetts Institute of Technology researchers said such 
an approach could minimize the need for induced sedation or 
paralysis currently necessary for some patients to use mech-
anical ventilation. Existing respirators don't consider the 
adaptive nature of breathing in their design; some ignore a 
patient's natural rhythm and pump air in and out of the 
lungs on set intervals. As a result, physicians often must 
sedate or paralyze patients to prevent them from fighting an
unfamiliar rhythm. Other respirators that are designed to 
rely on the patient to trigger the airflow are costly and 
tend to be unreliable for weak patients, such as newborns or
those in critical care. The MIT research suggested, however,
that if a doctor takes the patient's natural breathing rhy-
thm into account and sets the ventilator's rhythm in that 
same range, the patient will adapt and synchronize with the 
ventilator.
The study by Chi-Sang Poon and Gang Song of the Harvard-MIT 
Division of Health Sciences and Technology and Shawna Mac-
Donald of MIT's mechanical engineering department appears in
the online journal PLoS One.
  
------------------------------------------------------------
Brubeck Returns To Moscow on DVD

Here is a DVD that will be cherished forever. 10 years after 
his first trip to Moscow, celebrated jazz/classical pianist 
Dave Brubeck returns, this time to join the Russian National 
Orchestra. 

Playing both with a small group of jazz musicians as well as 
with the orchestra, Brubeck illustrates his mastery of two 
separate styles of music and allows the virtuosity of the 
Russian musicians to shine through. 

More than just a concert video, the program features rehearsals, 
Brubeck's musings on his long career, a jam session with Russian 
jazz musicians, and a rare seminar given by Brubeck. Grab a copy 
and own a piece a music history. Just $14.99. Visit: 
Brubeck Returns To Moscow on DVD
------------------------------------------------------------

         Possible Chlamydia vaccine target found

PITTSBURGH,  -- U.S. scientists have identified a potential 
target for a vaccine to fight Chlamydia -- the world's most 
prevalent sexually transmitted bacterial infection. Resear-
chers at the University of Pittsburgh Medical Center's Chil-
dren's Hospital, led by Dr. Toni Darville, identified a 
plasmid-deficient strain of Chlamydia trachomatis that, when
investigated in an animal model of genital tract infection, 
failed to cause disease. Plasmids are small molecules of 
DNA. "This finding represents a major step forward in our 
work to eventually develop a vaccine against chlamydial dis-
ease," said Darville, a professor of pediatrics and micro-
biology/immunology. "If we can identify plasmid-deficient 
derivatives of the C. trachomatis strains that infect hum-
ans, they would have the potential to serve as a vaccine 
against this disease." The study is reported in the Journal 
of Immunology.
  
        Heart attack blood vessel damage repaired

COLUMBUS, Ohio, -- U.S. scientists have identified the pro-
cess that damages blood vessels during and after a heart 
attack and have found a way to repair the vessels. Ohio 
State University researchers discovered delivering a vital 
molecule (tetrahydrobiopterin) that's depleted during a 
heart attack can reverse damage and help restore blood flow.
"This is a useful therapeutic approach and should be easy to
translate," said Jay Zweier, director of Ohio State's Davis 
Heart and Lung Research Institute and senior author of the 
study. "This should enable improved treatment of patients 
with unstable coronary syndromes and heart attacks, allowing
enhanced restoration of blood flow and preservation of heart
muscle at risk."The study that included Cristian Dumitrescu,
Yong Xia, Arturo Cardounel and Lawrence Druhan is reported 
online in the Proceedings of the National Academy of Sci-
ences.

------------------------------------------------------------
NOAH'S FLOOD ALERT
Be Alerted To Potential Floods Immediately...

Store: $12.99
OUR PRICE: $7.99

Have peace of mind with the Noah Flood Alert. This valuable 
item alerts you to any water overflow instantly! When water 
reaches the level of the sensor the LED Flood Alarm will flash 
and a loud alarm will sound. This alarm will eliminate 
flooded basements, garages, laundry rooms, bathrooms, spa's, 
pools, sinks, tubs water heaters & toilets.

Features 9 1/4 feet. cord, on and off switch. Grab one for 
your home. At $7.99 it's an investment that will pay for itself. 
VISIT: 
NOAH'S FLOOD ALERT
------------------------------------------------------------

          Action urged on menopause product ads

WASHINGTON, -- A U.S. nonprofit group says a red clover di-
etary supplement called Promensil is being deceptively mark-
eted to women to reduce menopause symptoms. The Center for 
Science in the Public Interest in Washington is urging the 
U.S. Food and Drug Administration and the Federal Trade Co-
mmission to crack down on Promensil's advertising and lab-
eling, which includes a recent television ad that calls it 
"the only supplement proven to reduce menopause symptoms" 
and ads in women's magazines that claim "22 clinical stud-
ies can't be wrong." Most of the research on Promensil that 
looked at hot flashes and other menopausal symptoms found 
the red clover supplement to be no more effective than a 
placebo, explained David Schardt, CSPI senior nutritionist. 
CSPI conducted an analysis of the scientific research on 
Promensil and in letters to the federal agencies it is urg-
ing that the government have the company reimburse consum-
ers, run corrective advertising and pay a fine.
 
        Neural basis of intelligence discovered

IRVINE, Calif., -- U.S. scientists have identified a brain 
network they believe is the biological basis of intell-
igence. Richard Haier of the University of California-Irvine
and Rex Jung of the University of New Mexico posit the fron-
tal and parietal lobes of the brain are primarily respon-
sible for intelligent thought. The parietal lobe is directly
behind the frontal lobe and both are known to process atten-
tion, memory, and language. The researchers said the integr-
ation of cognitive functions suggests intelligence is based 
on how efficiently networks in the frontal and parietal 
lobes process information. "Recent neuroscience studies 
suggest that intelligence is related to how well information
travels throughout the brain," said Haier, "Our review of 
imaging studies identifies the stations along the routes 
intelligent information processing takes. Once we know where
the stations are, we can study how they relate to intelli-
gence." Haier and Jung, who reached their conclusions after 
a review of 37 imaging studies of the brain related to 
intelligence, report their findings online in the journal 
Behavioral and Brain Sciences.
 
------------------------------------------------------------
LAVA LAMP NIGHT LIGHT

Store Price: $9.99 
DEAL PRICE: $3.99

Remember lava lamps when you were a kid? Now you can have 
the fun, nostalgia and ambience again... this time with 
these very cool mini Lava Lamp night-lights. 

Fashioned into the traditional lave style, the contents are 
non-toxic and child friendly. These blasts from the past have 
an easy to use On/Off switch. Head on over to the site to see 
a picture or to order. 
LAVA LAMP NIGHT LIGHT
------------------------------------------------------------

        Homocysteine therapy results questioned

STANFORD, Calif., -- A U.S. study suggests lowering homo-
cysteine levels in end-stage kidney disease patients does 
not improve survival or reduce vascular events. Patients 
with end-stage kidney disease are often treated with high 
doses of folic acid and B vitamins to lower their levels of 
the amino acid homocysteine, which has been associated with 
vascular disease. Dr. Rex Jamison of the Stanford University
School of Medicine and colleagues conducted a randomized 
controlled trial at 36 Veterans Administration medical cent-
ers involving end-stage kidney patients being given either a
daily capsule containing folic acid and vitamin B6 and B12 
or a placebo. After three months, homocysteine levels in 
vitamin group patients had been lowered by about 26 percent,
while the level decreased by 1.7 percent in the placebo 
group. But the researchers said the treatment had no sig-
nificant effect on the rate of death between the two groups 
-- 448 deaths in the vitamin group vs. 436 deaths in the 
placebo group. Treatment also had no significant effect on 
other outcomes such as heart attack, stroke and amputation.      
  
------------------------------------------------------------

Health Tips and Info From EVTV1.com Health Related Videos

************************************************************

ARCHIVES: Health Weekly Archives

************************************************************
End of HEALTH TIPS WEEKLY Copyright 2007 by NextEra Media. 
All rights reserved. Please forward this, in its entirety, 
to others. 

E-Mail this issue
Subscribe FREE to Health Tips Weekly by clicking here.

The Health Tips Weekly Forum
View this Forum | Post a topic to this forum





Home | Newest Editions | Most Popular Issues | Free Newsletters